Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cells Derived Exosomes Promote Healing of Large and Refractory Macular Holes

NCT03437759 is registered in ClinicalTrials.gov with Tianjin Medical University as lead sponsor.

NCT NCT03437759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03437759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cells Derived Exosomes Promote Healing of Large and Refractory Macular Holes
Lead sponsor
Tianjin Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
March 1, 2017
Completion date
December 30, 2021
Enrollment
44 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

macular holes